电话:
+86 (0512) 65829739
传真:
+86 (010) 6788 5057
电子邮件:
orders@antibodies-online.cn

Calreticulin 3 抗体 (AA 1-384)

This anti-Calreticulin 3 antibody is a 兔 多克隆 antibody detecting Calreticulin 3 in WB 和 IP. Suitable for 人.
产品编号 ABIN530564
发货至: 中国

Quick Overview for Calreticulin 3 抗体 (AA 1-384) (ABIN530564)

抗原

See all Calreticulin 3 (CALR3) 抗体
Calreticulin 3 (CALR3)

适用

  • 25
  • 7
  • 6
  • 3
  • 2
  • 2
  • 2
  • 2
  • 2
  • 1
  • 1

宿主

  • 19
  • 6

克隆类型

  • 21
  • 4
多克隆

标记

  • 17
  • 2
  • 2
  • 1
  • 1
  • 1
  • 1
This Calreticulin 3 antibody is un-conjugated

应用范围

  • 19
  • 10
  • 7
  • 4
  • 4
  • 4
  • 2
  • 2
  • 1
  • 1
Western Blotting (WB), Immunoprecipitation (IP)
  • 抗原表位

    • 6
    • 3
    • 3
    • 2
    • 1
    • 1
    • 1
    AA 1-384

    原理

    Rabbit polyclonal antibody raised against a full-length human CALR3 protein.

    序列

    MARALVQFWA ICMLRVALAT VYFQEEFLDG EHWRNRWLQS TNDSRFGHFR LSSGKFYGHK EKDKGLQTTQ NGRFYAISAR FKPFSNKGKT LVIQYTVKHE QKMDCGGGYI KVFPADIDQK NLNGKSQYYI MFGPDICGFD IKKVHVILHF KNKYHENKKL IRCKVDGFTH LYTLILRPDL SYDVKIDGQS IESGSIEYDW NLTSLKKETS PAESKDWEQT KDNKAQDWEK HFLDASTSKQ SDWNGDLDGD WPAPMLQKPP YQDGLKPEGI HKDVWLHRKM KNTDYLTQYD LSEFENIGAI GLELWQVRSG TIFDNFLITD DEEYADNFGK ATWGETKGPE REMDAIQAKE EMKKAREEEE EELLSGKINR HEHYFNQFHR RNEL

    交叉反应

    人, 小鼠

    产品特性

    Antibody reactive against mammalian transfected lysate.

    免疫原

    CALR3 (NP_659483.1, 1 a.a. ~ 384 a.a) full-length human protein.
  • 应用备注

    Optimal working dilution should be determined by the investigator.

    限制

    仅限研究用
  • 状态

    Liquid

    缓冲液

    No additive

    储存液

    Without preservative

    注意事项

    Aliquot to avoid repeated freezing and thawing.

    储存条件

    -20 °C

    储存方法

    Store at -20°C or lower. Aliquot to avoid repeated freezing and thawing.
  • 抗原

    Calreticulin 3 (CALR3)

    别名

    CALR3

    背景

    Full Gene Name: calreticulin 3
    Synonyms: CRT2,FLJ25355,MGC26577

    基因ID

    125972

    NCBI登录号

    NM_145046

    途径

    Activation of Innate immune Response
You are here:
Chat with us!